The onset of COVID-19 posed a grave challenge to researchers as ongoing trials were disrupted by social distancing. But the complicated new circumstances initiated a flurry of innovation that is still evolving the process of research, diagnostics, and approving new therapies.
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
Accelerating Progress in Cancer Research with Streamlined, Patient-Centric, Equitable Clinical Trials: Lessons From Pragmatica-Lung
Latest Comments & Discussions
Article > Re: Dr. Lynn M. Schuchter Makes the Art of Oncology and Cancer Care Central to Her ASCO Presidential Term
Article > Re: ASCO Remembers Former Board of Directors Member and Radiation Oncologist Dr. A. William Blackstock Jr.
Severe pain can lead one to places that are uncharted, unfamiliar, and unknown.
The application deadline is October 2, 2023.
Caregiver support is fragmented and inadequate. Here are 7 steps oncology professionals can take to address this urgent need.
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center.
Following the ASCO Annual Meeting, the conversations in the news, on social media, and in the hallways of our institutions tend to be dominated by advances in the field—promising new treatments, genetic targets unlocked, gains in overall survival.